Life after urological cancer - psychological issues
Urological Oncology, Page: 323-335
2015
- 6Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Captures6
- Readers6
Book Chapter Description
About half of patients treated for urological cancer will experience some degree of psychological distress and about a quarter have some degree of depression at some time in their illness. Patients with prostate cancer have lower levels of anxiety and depression compared to some other cancers. Psychological symptoms may be overshadowed by physical symptoms. However, useful clinical screening tests include the simple question “are you feeling down, depressed or hopeless?” and questions about sleep disturbance may identify depressed patients. The diagnosis of anxiety and depression may be helped by screening tools such as the Hospital Anxiety and Depression Scale (HADS) but we have found simple analogue scales (the Emotion Thermometers) much less laborious to use and equally accurate. Fatigue is one of the most common symptoms amongst cancer patients and can be worsened by radiotherapy and the use of androgen deprivation therapy (ADT). Fatigue is associated with depression in about half of patients. Graded aerobic exercise programmes should be considered for patients suffering from fatigue rather than the classical advice of rest, which could be detrimental. Minor degrees of cognitive dysfunction particularly reduction in immediate and working memory are common in men treated with ADT and occasionally can be severe. Recognition and treatment of distress, anxiety and depression can markedly improve the quality of life in patients treated for urological cancer.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84948783622&origin=inward; http://dx.doi.org/10.1007/978-0-85729-482-1_16; https://link.springer.com/10.1007/978-0-85729-482-1_16; https://dx.doi.org/10.1007/978-0-85729-482-1_16; https://link.springer.com/chapter/10.1007/978-0-85729-482-1_16
Springer Science and Business Media LLC
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know